Cargando…
Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study
Autores principales: | Yang, Yuan, Tang, Zengwei, Huang, Yuzhou, Hu, Qinglin, Wang, Shuqing, Ji, Jiang, Du, Yali, Yang, Chen, Chen, Miao, Hu, Shimin, Han, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169841/ https://www.ncbi.nlm.nih.gov/pubmed/37160872 http://dx.doi.org/10.1038/s41408-023-00845-3 |
Ejemplares similares
-
Effective treatment of refractory acquired pure red blood
cell aplasia with eltrombopag and sirolimus: a case
report
por: Huang, Yuzhou, et al.
Publicado: (2020) -
Induced complete remission faster in adult patients with acquired pure red cell aplasia by combining cyclosporine A with corticosteroids
por: Wu, Xuemei, et al.
Publicado: (2019) -
Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin
por: Watanabe, Kageaki, et al.
Publicado: (2020) -
Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin
por: Padhi, Somanath, et al.
Publicado: (2021) -
Pure red cell aplasia associated with autoimmune hepatitis successfully treated with cyclosporine A
por: Sato, Akira, et al.
Publicado: (2014)